Friday, October 30, 2009

PEDOT helps Artificial Limbs To Feel Heat, Cold, Touch !


We know that, Poly(3,4-ethylenedioxythiophene) or PEDOT (or sometimes PEDT) is a conducting polymer based on 3,4-ethylenedioxylthiophene or EDOT monomer. Advantages of this polymer are optical transparency in its conducting state, high stability and moderate band gap and low redox potential. A large disadvantage is poor solubility which is partly circumvented in the PEDOT:PSS composite, and the PEDOT-TMA material. (Note: Pedot is a transparent conductor. These conductors are used for LCDs and solar cells, among others.)

But more interesting property of this polymer has been established by Physicians at the American Society of Plastic Surgeons (ASPS). They have discovered that the polymer (3, 4-ethylenedioxythiophene or PEDOT) helps stimulate and grow new nerve fibers in severed nerves of amputees. Stimulating and growing nerve fibers are one of the first steps in providing amputees more neurologic control over their prosthetics. PEDOT functions similar to a wire. In the study, the PEDOT was placed in a tube, along with other biologic and synthetic materials, and grafted into the severed leg nerve of a rat. New nerve fibers grew and took over function for the dead or dysfunctional severed nerve springing targeted muscles to life.

Most interesting is the other study, plastic surgeons designed a cup containing cells and muscle that fits around the severed leg nerve of a rat. The PEDOT polymer was wrapped around all of the cells and muscle in the cup to provide an electrical charge. Tests were conducted 114 days after the procedure. The study found new muscle and blood vessels formed, nerve fibers sprouted, and muscle fibers started compensating for lost nerves. After tickling the rat's paw, doctors' were able to pick up electrical signals indicating sensation had returned. Hope in the days to come "real feeling" to artificial limbs.....

One can read/view this slide show..

Vegetables Can Protect Unborn Child Against Diabetes

Expecting mothers who eat vegetables every day seem to have children who are less likely to develop type 1 diabetes, a new study from the Sahlgrenska Academy has revealed......


More......Vegetables Can Protect Unborn Child Against Diabetes

Triple-combo Drug for Antiviral-resistant H1N1 ?

In laboratory testing, the triple combination of oseltamivir (Tamiflu), amantadine (Symmetrel) and ribavirin showed a significant capacity to stop flu-virus growth, says Mark Prichard....


More...http://www.sciencedaily.com/releases/2009/10/091027132426.htm

Wednesday, October 28, 2009

Scientists Discover Gene that 'Cancer-Proofs' Rodent's Cells

In my earlier blog, I did mention about how naked mole rats may help cure cancer. The same researchers have achieved something interesting i.e., they have discovered have discovered the gene that "cancer-proofs the naked mole". For details...

Junk DNA Mechanism That Prevents Two Species From Reproducing Discovered

Cornell researchers have discovered a genetic mechanism in fruit flies that prevents two closely related species from reproducing, a finding that offers clues to how species evolve.


More ...Junk DNA Mechanism That Prevents Two Species From Reproducing Discovered

New 'Schizophrenia Gene' Prompts Researchers To Test Potential Drug Target

The newfound gene, dubbed KIAA1212, serves as a bridge linking two schizophrenia genes: DISC1 and AKT. Suspecting KIAA1212 as one of many potential binding partners interacting with DISC1, whose name is an acronym for "Disrupted-in-Schizophrenia," the researchers genetically shut down the production of DISC1 proteins in newly born neurons in the hippocampus region of an adult mouse brain. The hippocampus contains a niche where native stem cells give rise to fully developed new neurons


Read : New 'Schizophrenia Gene' Prompts Researchers To Test Potential Drug Target

Saturday, October 24, 2009

Now Cobroxin, available online......

In my earlier blog, I did mention about the launch of Cobroxin as OTC pain reliever. Now its available online. More...

New insight on skin pigmentation

Scientists at Karolinska Institutet in Stockholm have now shown that most melanocytes actually appear later on in foetal development from an immature cell type that exists in the skin's nerve fibres (as against reported earlier, i.e., melanocytes bud off from the spinal cord at an early foetal stage and then migrate to the skin where they remain for the rest of their lives). These cells, called Schwann cell precursors (SCPs), can also be found in adults. In addition to this, the scientists have demonstrated how neuronal damage in adults can excite the maturation of melanocytes to form hyperpigmentation around the affected nerves.

Their results also shed new light on SCP cells, which were previously seen as an immature form of supportive cells the nervous system. The researchers describe how a change in cell signalling can make the SCP cells in the skin develop into pigment cells instead, and argue that SCP cells are really a kind of stem cell. Congrats for this achievement...

Ref : http://ki.se/ki/jsp/polopoly.jsp?a=85186&d=2637&l=en&newsdep=2637

Phase III clinical study of trabedersen....

In my earlier blogs, did mention about the "antisense drugs belonging to (Geron corporation) phosphorothioate antisense oligonucleotides" . I did also mention that there are many companies working with this field (antisense). Yes now Antisense Pharma GmbH has announced that, it has received the approval by Health Canada for its pivotal Phase III clinical trial SAPPHIRE in patients with recurrent or refractory anaplastic astrocytoma. The SAPPHIRE study is a randomized, active-controlled, clinical trial designed to confirm the efficacy and safety of the investigational drug trabedersen (AP 12009 a phosphorothioate antisense oligonucleotide), observed in previous clinical studies. Trabedersen is being investigated as monotherapy compared to current standard therapy with temozolomide (alternatively BCNU (carmustine)). The results of a previous randomized, active-controlled Phase IIb study show that the novel, targeted therapy holds significant promise. Hope in the days to come, more drugs from this class of compounds...

Ref :http://www.anticancer.de/index.php?id=38.

I found this video, interesting (mode of action of trabedersen)

Friday, October 23, 2009

Researchers Discover RNA Repair System In Bacteria

Researchers Discover RNA Repair System In Bacteria

Identifying Safe Stem Cells To Repair Spinal Cords

In my earlier blog, I did mention the euphoria surrounding the stem cell and how many companies tried to fool people by claiming that, they can cure anything and everything with the help of stem cell. But this is something really interesting......

Read .....Identifying Safe Stem Cells To Repair Spinal Cords

Wednesday, October 21, 2009

Colcrys approved by FDA for prevention of gout flares...


Colchicine is a toxic natural product and secondary metabolite, originally extracted from plants of the genus  Colchicum (Autumn crocus, Colchicum autumnale, also known as "Meadow saffron"). It was used originally to treat rheumatic complaints, especially gout.

Recently (July 30, 2009 ), US FDA has approved Colcrys(TM) (colchicine, USP) for the prophylaxis (prevention) of gout flares. Colcrys was first approved by the FDA on for the treatment of acute gout flares when taken at the first sign of a flare. Colcrys is also indicated for the treatment of Familial Mediterranean Fever (FMF) in adults and children 4 years of age or older. Colcrys is available via prescription at pharmacies nationwide.

As per the claim by the company (URL Pharma, Inc.) , two randomized clinical trials assessed the efficacy of colchicine 0.6 mg twice a day for the prophylaxis of gout flares in patients initiating treatment with uric-acid lowering therapy. In both trials, treatment with colchicine decreased the frequency of gout flares. Colchicine has been shown to be well-tolerated when paired with uric acid-lowering agents such as allopurinol. The dosing of Colcrys for gout flare prophylaxis is one tablet (0.6 mg) once or twice a day. The maximum daily dose for prophylaxis is two tablets (1.2 mg).

Uric acid-lowering agents are highly effective and well-established in chronic gout management, but the initiation of this therapy may sometimes trigger a gout flare, where as Colchicine has been proven to be effective in preventing flares when given in conjunction with uric acid-lowering therapy, except for the mild diarrhea. Hope patients suffering from gout will breathe a sigh of relief..

Ref : http://www.drugs.com/colcrys.html

Fluarix seasonal influenza vaccine approved by the FDA

Fluarix seasonal influenza vaccine approved by the FDA

Patients with chronic hepatitis C can benefit by drinking coffee

Patients with chronic hepatitis C and advanced liver disease who drink three or more cups of coffee per day have a 53% lower risk of liver disease progression than non-coffee drinkers according to a new study. The study found that patients with hepatitis C-related bridging fibrosis or cirrhosis who did not respond to standard disease treatment benefited from increased coffee intake. An effect on liver disease was not observed in patients who drank black or green tea.

Read......

Patients with chronic hepatitis C can benefit by drinking coffee
BlogNation.com